EP
LLY icon

Essential Planning’s Eli Lilly LLY Stock Holding History

Essential Planning’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61M Sell
2,839
-6,885
-71% -$6.98M 0.83% 24
2025
Q4 		$10.4M Hold
9,724
– – 3.33% 6
2025
Q3 		$7.42M Sell
9,724
-1,273
-12% -$947K 2.55% 7
2025
Q2 		$8.57M Sell
10,997
-22
-0.2% -$17.1K 3.19% 6
2025
Q1 		$9.1M Sell
11,019
-705,062
-98% -$587M 3.67% 6
2024
Q4 		$594M Buy
716,081
+705,076
+6,407% +$584M 3.87% 5
2024
Q3 		$9.75M Sell
11,005
-1,261
-10% -$1.13M 4% 5
2024
Q2 		$11.1M Sell
12,266
-31
-0.3% -$24.8K 4.89% 5
2024
Q1 		$7.17M Hold
12,297
– – 3.59% 6
2023
Q4 		$7.17M Buy
12,297
+1
+0% +$584 3.62% 6
2023
Q3 		$6.6M Hold
12,296
– – 3.66% 5
2023
Q2 		$5.77M Sell
12,296
-42
-0.3% -$17.6K 3.29% 5
2023
Q1 		$4.17M Buy
12,338
+2
+0% +$675 2.53% 12
2022
Q4 		$3.93M Buy
+12,336
New +$4.37M 3.01% 9

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Essential Planning's LLY Position: Q1 2026 in Review

Essential Planning reduced its Eli Lilly (LLY) stake by 71% in Q1 2026, selling an estimated $6.98M and leaving 2,839 shares worth $2.61M. The position accounts for 0.83% of the portfolio, ranked #24.

Essential Planning first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $594M in Q4 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Essential Planning held 2,839 shares of Eli Lilly worth $2.61M as of Q1 2026.
  • Essential Planning sold 6,885 Eli Lilly shares in Q1 2026, an estimated $6.98M.
  • Eli Lilly made up 0.83% of Essential Planning's portfolio in Q1 2026, its #24 holding.
  • Essential Planning first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Essential Planning's Eli Lilly position peaked at $594M in Q4 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Essential Planning's 13F filing for Q1 2026, filed 23 Apr 2026.